IP Library Granted Patent US 8,712,531
Granted Patent B2
US 8,712,531 · App. 13/480,063 · Granted Apr 29, 2014

Automatic baroreflex modulation responsive to adverse event

Inventors: Robert S Kieval (Medina, MN); Matthew M Burns (Orono, MN); David J Serdar (Shorewood, MN)
Assignee: CVRx, Inc.
A61N1/36053A61N1/3611A61N1/36135
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,712,531
App. No.
13/480,063
Granted
Apr 29, 2014
Kind
B2
Abstract

A system for providing baroreflex stimulation comprises a sensor to detect a parameter and provide a signal indicative of the parameter and a baroreflex stimulator. The baroreflex stimulator includes a driver to provide a control signal adapted to deliver a baroreflex therapy and a controller to receive the signal indicative of the parameter and modulate the control signal based on the signal indicative of the parameter to change the baroreflex therapy from a first baroreflex therapy to a second baroreflex therapy.

Claims (23)

1. A method for operating an implantable medical device, the medical device having a control system contained within an implantable housing, and an electrode coupled to the control system and implanted in contact with a blood vessel, the method comprising:

performing a first therapy using the medical device according to a program stored in the control system, including delivering a first baroreflex stimulation signal through the electrode to stimulate a baroreceptor within a wall of the blood vessel, the first therapy programmed to treat a physiological condition through a baroreflex response; and

in response to detecting a predetermined threshold value, automatically performing a second therapy using the medical device according to a program stored in the control system, including delivering a second baroreflex stimulation signal through the electrode to stimulate the baroreceptor, the second therapy programmed to treat the physiological condition through a baroreflex response, wherein the second therapy is different from the first therapy.

2. The method of claim 1 , wherein performing the first therapy includes withholding therapy and performing the second therapy includes providing baroreflex stimulation.

3. The method of claim 1 , wherein performing the first therapy includes providing baroreflex stimulation and performing the second therapy includes withholding therapy.

4. The method of claim 1 , wherein the electrode is positioned within a blood vessel.

5. The method of claim 1 , wherein the electrode is positioned at least partially surrounding a blood vessel.

6. A method for operating an implantable medical device, the medical device having a control system contained within an implantable housing, and an electrode coupled to the control system and implanted in contact with a blood vessel, the method comprising:

performing a first therapy using medical device according to a program stored in the control system, including delivering a first baroreflex stimulation signal through the electrode to stimulate a baroreceptor within a wall of the blood vessel, the first therapy programmed to treat a physiological condition through a baroreflex response; and

in response to detecting a predetermined parameter, automatically performing a second therapy using the medical device according to a program stored in the control system, including delivering a second baroreflex stimulation signal through the electrode to stimulate the baroreceptor, the second therapy programmed to treat the physiological condition through a baroreflex response, wherein the second therapy is different from the first therapy.

7. The method of claim 6 , wherein the predetermined parameter is selected from the set consisting of: a blood pressure below a lower predetermined threshold, a blood pressure above a higher predetermined threshold, and a specific physiologic event indicative of a need for therapy to treat hypertension and/or heart failure.

8. The method of claim 1 , wherein the predetermined threshold value is selected from the group consisting of: blood pressure, heart rate, body movement, activity levels, respiration, and nerve activity.

9. The method of claim 1 ,

wherein each of the first therapy and the second therapy include at least one characteristic selected from the group consisting of: pulse amplitude, pulse frequency, pulse width, pulse duration, pulse waveform, pulse polarity and pulse phase, and

wherein the difference between the second therapy and the first therapy comprises a difference in the at least one characteristic.

10. The method of claim 1 , wherein the physiological condition is selected from the group consisting of: hypertension, heart failure, cardiovascular disorders, renal disorders, nervous system disorders and low blood pressure.

11. The method of claim 1 , wherein the electrode is implanted in contact with a wall of a blood vessel selected from the group consisting of: a carotid sinus, an aortic arch, a common carotid artery, a subclavian artery, a brachiocephalic artery, and a heart.

12. The method of claim 6 , wherein the predetermined parameter is selected from the group consisting of: blood pressure, heart rate, body movement, activity levels, respiration, and nerve activity.

13. The method of claim 6 ,

wherein each of the first therapy and the second therapy include at least one characteristic selected from the group consisting of: pulse amplitude, pulse frequency, pulse width, pulse duration, pulse waveform, pulse polarity and pulse phase, and

wherein the difference between the second therapy and the first therapy comprises a difference in the at least one characteristic.

14. The method of claim 6 , wherein the physiological condition is selected from the group consisting of: hypertension, heart failure, cardiovascular disorders, renal disorders, nervous system disorders and low blood pressure.

15. The method of claim 6 , wherein the electrode is implanted in contact with a wall of a blood vessel selected from the group consisting of: a carotid sinus, an aortic arch, a common carotid artery, a subclavian artery, a brachiocephalic artery, and a heart.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2012
From: KIEVAL, ROBERT S.; BURNS, MATTHEW M.; SERDAR, DAVID J.
To: CVRX, INC.
Reel/Frame 028612/0166 →
Continuity (6)
Continuation 11482358 · Jul 7, 2006
Continuation 10402911 · Mar 27, 2003
Continuation In Part 09963777 · Sep 26, 2001
Continuation In Part 09671850 · Sep 27, 2000
Provisional Application 60368222 · Mar 27, 2002
Related Publication 20120232613A1 · Sep 13, 2012